When the performance of AI models was assessed within stratified patient subgroups, such as only high-grade breast cancers or only MSI-positive tumors, accuracy fell substantially, revealing that the ...
DexCom, Inc. (DXCM) 47th Annual Raymond James Institutional Investor Conference March 2, 2026 1:05 PM ESTCompany ParticipantsJereme Sylvain - Executive ...
Additionally, a webcast of this earnings call will be available in the Investor Relations section of our website at In conjunction with today's call, we have posted a quarterly earnings presentation ...
Alphatec Holdings, Inc. (NASDAQ:ATEC) Q4 2025 Earnings Call Transcript February 24, 2026 Alphatec Holdings, Inc. misses on earnings expectations. Reported EPS is $-0.1448 EPS, expectations were $0.04.
The first and only approved achondroplasia therapy to provide continuous systemic exposure to CNP over the weekly dosing intervalCommercial ...
Elanco Animal Health Incorporated. As highlighted on slide 4, Elanco delivered a strong fourth quarter, with 9% organic ...
Artificial intelligence tools are increasingly being developed to predict cancer biology directly from microscope images, ...
Investors don't read 40-page plans. Learn how to condense your vision, your traction and your ask into a winning narrative they'll actually engage with.
University of Warwick research warns that popular deep learning systems trained for cancer pathology may be relying on hidden ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results